Product Information
DICLOFENAC SODIUM 1% GEL is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.0813 per GM under NDC 45802095301. Its NADAC has been published 311 times since Oct 21, 2020.
FDA first approved this application on May 16, 2019.
Strength
10 mg/g
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802095301
Classification
Generic
Dosage Form
GEL
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
DICLOFENAC SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA211253FDA Approved
5/16/2019
On Market Since
7/9/2020
Pharmacological Classes
Price Statistics
The NADAC for DICLOFENAC SODIUM 1% GEL has been published 311 times since Oct 21, 2020, and over the history we have for it it has declined 19.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0813 per GM |
|---|---|
| All-time high | $0.1119 (Dec 16, 2020) |
| All-time low | $0.0788 (Jul 17, 2024) |
| 52-week high | $0.0953 |
| 52-week low | $0.0813 |
| Median price | $0.0925 |
| Average price | $0.0931 |
| Largest weekly change | +20.8% (Aug 21, 2024) |
| Weeks tracked | 311 |
| Tracking since | Oct 21, 2020 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 15% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Padagis Israel Pharmaceuticals Ltd manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
diclofenac sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DICLOFENAC SODIUM 1% GEL?
The current National Average Drug Acquisition Cost (NADAC) for DICLOFENAC SODIUM 1% GEL, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.0813 per GM (NDC 45802095301), effective Sep 30, 2026.
How has the price of DICLOFENAC SODIUM 1% GEL changed over time?
Over the history we have for it, the NADAC for DICLOFENAC SODIUM 1% GEL has declined 19.6%. It has been tracked across 311 weekly CMS publications since Oct 21, 2020.
What are the highest and lowest recorded NADAC prices for DICLOFENAC SODIUM 1% GEL?
Since Oct 21, 2020, the NADAC for DICLOFENAC SODIUM 1% GEL has ranged from a low of $0.0788 (Jul 17, 2024) to a high of $0.1119 (Dec 16, 2020), with a median of $0.0925 per GM.
Are there cheaper alternatives to DICLOFENAC SODIUM 1% GEL?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GS ARTHRITIS PAIN 1% GEL, is $0.0691 per GM — about 15% below DICLOFENAC SODIUM 1% GEL.
Who manufactures DICLOFENAC SODIUM 1% GEL?
DICLOFENAC SODIUM 1% GEL (NDC 45802095301) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.